Coherus BioSciences, Inc. (CHRS) Debt-to-equity % [USD] 2015 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Coherus BioSciences, Inc. quarterly Debt-to-equity history and growth rate from 2015 to 2024.
Coherus BioSciences, Inc. Debt-to-equity for the quarter ending March 31, 2024 was -519 %, a 3.22% increase year-over-year.

Debt-to-equity, Quarterly (% [USD])

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	-519	+17.3	+3.22%	Mar 31, 2024
Q4 2023	-399	+589	+59.6%	Dec 31, 2023
Q3 2023	-402	+24.7 K	+98.4%	Sep 30, 2023
Q2 2023	-414	-1.49 K	-139%	Jun 30, 2023
Q1 2023	-536	-1.13 K	-190%	Mar 31, 2023
Q4 2022	-988	-1.44 K	-316%	Dec 31, 2022
Q3 2022	-25.1 K	-25.4 K	-7628%	Sep 30, 2022
Q2 2022	1.07 K	+797	+290%	Jun 30, 2022
Q1 2022	593	+341	+135%	Mar 31, 2022
Q4 2021	457	+241	+111%	Dec 31, 2021
Q3 2021	334	+101	+43.2%	Sep 30, 2021
Q2 2021	275			Jun 30, 2021
Q1 2021	253			Mar 31, 2021
Q4 2020	216			Dec 31, 2020
Q3 2020	233			Sep 30, 2020
Q4 2018	1.49 K	+1.21 K	+426%	Dec 31, 2018
Q3 2018	498	+184	+58.9%	Sep 30, 2018
Q2 2018	354	-19.2	-5.14%	Jun 30, 2018
Q1 2018	461	-647	-58.4%	Mar 31, 2018
Q4 2017	284	+1.54 K		Dec 31, 2017
Q3 2017	313	+1.3 K		Sep 30, 2017
Q2 2017	374	+1.44 K		Jun 30, 2017
Q1 2017	1.11 K	-163	-12.8%	Mar 31, 2017
Q4 2016	-1.26 K	-1.64 K	-428%	Dec 31, 2016
Q3 2016	-984	-1.21 K	-533%	Sep 30, 2016
Q2 2016	-1.07 K	-2.09 K	-205%	Jun 30, 2016
Q1 2016	1.27 K			Mar 31, 2016
Q4 2015	384			Dec 31, 2015
Q3 2015	227			Sep 30, 2015
Q2 2015	1.02 K			Jun 30, 2015

* An asterisk sign (*) next to the value indicates that the value is likely invalid.